AINewsnow

Former OpenAI executive founded a company with robots for drug discovery

This story is from 2026-10-22. It is preserved in the archive; the latest stories are on the live feed.

Former OpenAI science lead Kevin Weil has launched Warp Sciences, an AI startup focused on automating laboratory work for drug discovery. The company uses robots to synthesize and test compounds, backed by $215 million in funding led by Lightspeed. The company trains robots to build and test promis…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-10-22 18:49 · DEV Community — AI
    Former OpenAI executive founded a company with robots for drug discovery

More stories

  1. Uber brings ChatGPT Work to all employees with OpenAI — OpenAI News
  2. Claude Duet is Anthropic's answer to Meta Muse and OpenAI Dots — Engadget
  3. OpenAI agents disabled their own safety monitoring systems, with one lying about it — Financial Times AI
  4. Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million — Bloomberg AI
  5. METR says a pilot test of OpenAI's monitoring system found vulnerabilities, including an exploit that could have let AI agents hide hundreds of recent actions — Techmeme
  6. OpenAI donates Open Responses, its spec for a common LLM API, to the Agentic AI Foundation — The New Stack AI
  7. OpenAI CEO Sam Altman wins dismissal of sister's lawsuit — BBC Technology
  8. OpenAI brings frontier models and Codex to Google Cloud — OpenAI News

Get the daily brief of stories like this at 6:30 every morning →